Beyond analysts' top-and-bottom-line estimates for Copa Holdings (CPA), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2025.

Regardless of this year's stock market volatility, the explosive demand for semiconductors and microchips that has grabbed news headlines and led the market higher over the past few years remains.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Marex To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Marex between May 16, 2024 and August 5, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Nov. 14, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Marex Group plc ("Marex" or the …

Actelis Networks, Inc. (ASNS) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to a loss of $0.09 per share a year ago.

CG Oncology, Inc. (CGON) came out with a quarterly loss of $0.57 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.3 per share a year ago.

MILWAUKEE , Nov. 14, 2025 /PRNewswire/ -- The Ademi Firm is investigating Cidara (Nasdaq: CDTX) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Merck. Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Firefly Aerospace To Contact Him Directly To Discuss Their Options If you purchased or otherwise acquired: (a) Firefly common stock pursuant and/or traceable to the Offering Documents (defined below) issued in connection with the Company's initial public offering conducted on or about August 7, 2025 (the "IPO" or "Offering"); and/or (b) Firefly securities between August 7, 2025 and September 29, 2025, both dates inclusive (the "Class Period") and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at …

BRK.B and MKL face shifting insurance trends despite their diversified business models. Let's see which conglomerate's fundamentals shine the brightest.

SAN DIEGO, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Soleno Therapeutics, Inc. (NASDAQ: SLNO) focused on whether Soleno and certain of its executives made false and/or misleading statements and/or failed to disclose material information to investors.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Molina To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Molina between February 5, 2025 and July 23, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Nov. 14, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Molina Healthcare, Inc. ("Molina" or the …

Investors need to pay close attention to BBWI stock based on the movements in the options market lately.

F plans to ramp up F-Series and Super Duty output in 2026, adding jobs and capacity to recoup volumes lost after the Novelis fire.

MNST's expanding zero-sugar lineup is capturing shifting consumer tastes and fueling strong momentum across global energy drink markets.

EVI Industries posts a year-over-year decline in Q1 earnings as integration expenses and tech investments pressure margins, despite delivering record revenues and gross profit.

Eli Lilly's next-gen obesity drugs, led by oral orforglipron and triple-acting retatrutide, aim to reshape the fast-growing weight-loss market.

ACM gears up to report Q4 results as estimates point to year-over-year gains amid strong infrastructure spending and broad market momentum.

AVGO's surging XPU demand, record AI revenues and expanding portfolio fuel momentum despite margin pressure and premium valuation.

Society Pass Incorporated (SOPA) came out with a quarterly loss of $0.89 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.48 per share a year ago.

Natural Gas Services (NGS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

TSLA gears up for a major 2026 capex surge as it doubles down on AI, autonomy and robotics to fuel its next growth phase.